INDBInternet News Database 2.5 Updated 1 min ago · 315 sources Show or hide images Light or dark

US FDA Approves At-home Use Of BioXcel's Agitation Drug

Save Like Comments Compare coverage

Summary

The US Food and Drug Administration on Monday approved at-home use of ⁠BioXcel Therapeutics' drug, Igalmi, for agitation associated with schizophrenia or bipolar... Reuters Health Information

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    US FDA Approves At-home Use Of BioXcel's Agitation Drug

    The US Food and Drug Administration on Monday approved at-home use of ⁠BioXcel Therapeutics' drug, Igalmi, for agitation associated with schizophrenia or bipolar... Reuters Health Information

Comments

Comments need JavaScript.